@article{de0480c15808455680e635b7a33bef91,
title = "Representation of Patients With Cardiovascular Disease in Pivotal Cancer Clinical Trials",
keywords = "United States Food and Drug Administration, cancer, cardiovascular disease, clinical trials as topic, underrepresentation",
author = "Janice Bonsu and Lawrence Charles and Avirup Guha and Farrukh Awan and Jennifer Woyach and Vedat Yildiz and Lai Wei and Hani Jneid and Daniel Addison",
note = "Funding Information: This work was supported in part by an NIH P50-CA140158 grant. Dr Awan was supported by NIH grant R35-CA197734. Dr Woyach was supported by NIH grants K23-CA178183 and R01-CA197870. Dr Addison was supported by NIH grant K12-CA133250. Funding Information: Dr Awan has received research funding from Innate Pharma and provided consulting services to Gilead Sciences, Pharmacyclics, Inc, Janssen, Abbvie, and Novartis Oncology. The other authors report no conflicts.",
year = "2019",
month = may,
day = "28",
doi = "10.1161/CIRCULATIONAHA.118.039180",
language = "English (US)",
volume = "139",
pages = "2594--2596",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "22",
}